These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma]. Arima M; Yukawa T; Terashi Y; Sagara H; Makino S Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513 [TBL] [Abstract][Full Text] [Related]
6. PAF antagonism as an approach to the treatment of airway hyperreactivity. Meade CJ; Heuer H Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S79-82. PubMed ID: 2003696 [TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor and asthma. Barnes PJ Ann N Y Acad Sci; 1991; 629():193-204. PubMed ID: 1659278 [No Abstract] [Full Text] [Related]
8. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. Nagase T; Ishii S; Shindou H; Ouchi Y; Shimizu T Am J Respir Crit Care Med; 2002 Jan; 165(2):200-5. PubMed ID: 11790655 [TBL] [Abstract][Full Text] [Related]
9. [The potential role and mechanism of leukotriene and platelet-activating factor in allergic disease]. Yoshida K; Suko M Nihon Rinsho; 1993 Mar; 51(3):631-7. PubMed ID: 8492436 [TBL] [Abstract][Full Text] [Related]
10. Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs. Inoue H; Aratani H; Takishima T; Kagoshima M; Iwahisa Y; Terasawa M J Lipid Mediat; 1992; 5(2):173-6. PubMed ID: 1525360 [TBL] [Abstract][Full Text] [Related]
11. [The role of platelet activating factor in the pathogenesis of asthma]. Péc M; Visnovský P; Dobrota D; Dobiás J; Lazár J Bratisl Lek Listy; 1993 Sep; 94(9):507-9. PubMed ID: 8004503 [TBL] [Abstract][Full Text] [Related]
12. [Role of platelet activating factor and its antagonists in bronchial asthma]. Massion PB; Frans A Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101 [TBL] [Abstract][Full Text] [Related]
13. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372 [TBL] [Abstract][Full Text] [Related]
14. The role of eosinophils in asthma. Kroegel C Lung; 1990; 168 Suppl():5-17. PubMed ID: 2117155 [TBL] [Abstract][Full Text] [Related]
16. Role of leukotrienes and platelet activating factor in allergic bronchoconstriction and their interactions in guinea pig airway in vivo. Saito M; Fujimura M; Ogawa H; Matsuda T Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):579-85. PubMed ID: 8415807 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium. Casale TB; Erger RA; Little MM Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250 [TBL] [Abstract][Full Text] [Related]
18. The effects of hetrazepine PAF antagonists in preclinical models of asthma. Heuer HO Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor. Mizuki M; Komatsu H; Akiyama Y; Iwane S; Tsuda T Life Sci; 1999; 65(20):2031-9. PubMed ID: 10579457 [TBL] [Abstract][Full Text] [Related]
20. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Hozawa S; Haruta Y; Ishioka S; Yamakido M Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1198-202. PubMed ID: 7551370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]